Navigation Links
Cellectis Receives Payment for License to Homologous Recombination Patents
Date:4/4/2011

PARIS, April 4, 2011 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced today that it has signed a license agreement with a pharmaceutical company covering certain uses of its homologous recombination technology patents and patent applications, in the oncology therapeutic field.

This agreement has triggered an immediate payment of euro 3M ($4.2M) to Cellectis.

Further details of the arrangement have not been disclosed.

About Cellectis

Cellectis improves life by applying its genome engineering expertise to a broad range of applications, including human therapeutics, bioresearch and agriculture. Cellectis is listed on the NYSE-Euronext Alternext market (code: ALCLS) in Paris.

More information at www.cellectis.com  

Follow Cellectis on Twitter at www.twitter.com/cellectis.  

Disclaimer

This press release and the information contained herein do not constitute an offer to sell or subscribe, or a solicitation of an offer to buy or subscribe, for shares in Cellectis in any country. This press release contains forward-looking statements that relate to the Company's objectives based on the current expectations and assumptions of the Company's management only and involve unforeseeable risk and uncertainties that could cause the Company to fail to achieve the objectives expressed by the forward-looking statements above.

For further information, please contact:


'/>"/>
SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
2. Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
4. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
5. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
6. Cellectis Unveils Its New Corporate Website
7. Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store
8. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
9. Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
10. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
11. Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Die Übersetzungen wurden von PRNewswire ... der englischen Version handelt es sich um ... Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für ... -Definition [1] als kontrolliert gelten können ... von vier Denkweisen zugeordnet werden können, die alle von ...
(Date:5/23/2013)... Graphite Metallizing Corporation announces a series ... stainless steel pillow blocks. This series combines the ... application and installation versatility of pillow blocks. , ... exceptionally well when submerged in water, water-soluble chemicals ... acids, alkalies, hydrocarbons, black liquor, and liquid gases. ...
(Date:5/23/2013)... PI’s new LPS-24 positioners are less ... travel range with closed-loop sensor resolution up to ... new positioners the ideal choice for high precision ... is also available. , More Information: Specifications ... found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 , Reference-Class ...
(Date:5/23/2013)... On April 19th the Center ... search for the growing antibiotic resistant bacteria that may ... year long study were released late last month showing ... over previous years. For those suffering from bacteria driven ... resistant bacteria in food, may eventually help breed acne ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2
... Oct. 15 /PRNewswire-Asia/ -- Sundia MediTech, a leading,pharmaceutical R&D ... D. Maher has been appointed Senior Vice President of ... Prior to joining Sundia, Mr. Maher was Executive Vice ... Group, a CRO company in,Florida, USA. Azopharma,s CRO ...
... ... pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a ... Stemedica,s high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) ... 2009 with the FDA, Stemedica is planning to file an IND application ...
... The inaugural Advanced Bioenergy Conference and Expo, scheduled ... in Sacramento, Calif. will feature a number of internationally ... chain. , During the opening plenary session, Doug Cameron, ... & Co., will present The Investment Climate for ...
Cached Biology Technology:Sundia Appoints Charles D. Maher as Senior Vice President of Sales and Marketing 2Stemedica Completes Meeting with the FDA 2Stemedica Completes Meeting with the FDA 3Internationally Recognized Bioenergy Experts Convene in Sacramento 2
(Date:5/24/2013)... Cancer cells spread and grow by avoiding detection and ... system can help to eliminate cancer cells; however, there ... ignore cancer cells. Regulatory T cells are immune cells ... this issue of the Journal of Clinical Investigation ... found that regulatory T cells that infiltrate tumors express ...
(Date:5/23/2013)... Frontiers in Plant Science , ... gene content and promoter evolution among grasses , ... of stretches of DNA that undergo little change in ... not code for any proteins. Some of these evolutionarily ... to regulate the expression of other genes or the ...
(Date:5/23/2013)... discovering the new mechanism by which estrogen suppresses lipid ... a potential new approach toward treating certain liver diseases. ... colleagues believe they are changing long-held views in the ... of the journal Science Signaling . , "The ... has been that only receptors located in the nucleus ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... do it. Bees do it. Even environmentally stressed fish do ... of Zoology is the first in the world to discover ... His research may provide the key to the survival of ... ocean ― currently threatened by global warming. In ...
... been hanging together rather than going it alone much longer ... of Volvox algae made the transition from being ... 200 million years ago, during the Triassic Period. ... included tree ferns, dinosaurs and early mammals. Previous estimates had ...
... flies mate, the females, genes are activated to roughly ... This is shown in a study at Uppsala University ... Journal of Evolutionary Biology .* Using a ... researchers at Uppsala University can show how fruit fly ...
Cached Biology News:Changing sexes on the sea floor 2How Volvox got its groove 2How Volvox got its groove 3
... An excellent ion chromatography system . ... twelve ranges from 0.01S to 5000S, houses the ... suppressor module CE 4715, is available. Data ... and software., Solvent delivery is by the high ...
... and other fluid sources for 4 vessels ... of each individual pump is controlled electronically. ... exactly maintained. ,High-precision controlled peristaltic pumps ... which allows flow rates between 0.01 to ...
... The loxP-amp-loxP cassette is designed ... The prokaryotic promoter gb2 driving the ... modified version of the Em7 promoter. It ... used Tn5 promoter. A synthetic polyadenylation signal ...
... the fast and simple integration of FRT-sites ... (for the generation of transgenic mouse models). ... allow neomycin / kanamycin selection in prokaryotic ... promoter (gb2) for expression of kanamycin resistance ...
Biology Products: